AKTX
Akari Therapeutics
AKTX
AKTX
15 hedge funds and large institutions have $14.5M invested in Akari Therapeutics in 2017 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
61% less capital invested
Capital invested by funds: $37M → $14.5M (-$22.5M)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$987K | |
| 2 | +$277K | |
| 3 | +$262K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$57K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$32K |
Top Sellers
| 1 | -$1.53M | |
| 2 | -$1.05M | |
| 3 | -$516K | |
| 4 |
QF
QVT Financial
New York
|
-$310K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$94.2K |